- Home
- EVN vs LAB Comparison
EVN vs LAB Comparison
Compare EVN & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVN
- LAB
- Stock Information
- Founded
- EVN 1998
- LAB 1999
- Country
- EVN United States
- LAB United States
- Employees
- EVN N/A
- LAB N/A
- Industry
- EVN Investment Bankers/Brokers/Service
- LAB Biotechnology: Laboratory Analytical Instruments
- Sector
- EVN Finance
- LAB Industrials
- Exchange
- EVN Nasdaq
- LAB Nasdaq
- Market Cap
- EVN 444.3M
- LAB 504.2M
- IPO Year
- EVN N/A
- LAB 2011
- Fundamental
- Price
- EVN $11.06
- LAB $1.11
- Analyst Decision
- EVN
- LAB Hold
- Analyst Count
- EVN 0
- LAB 2
- Target Price
- EVN N/A
- LAB $1.35
- AVG Volume (30 Days)
- EVN 101.2K
- LAB 1.6M
- Earning Date
- EVN 01-01-0001
- LAB 11-04-2025
- Dividend Yield
- EVN 4.78%
- LAB N/A
- EPS Growth
- EVN N/A
- LAB N/A
- EPS
- EVN 0.34
- LAB N/A
- Revenue
- EVN N/A
- LAB $169,737,000.00
- Revenue This Year
- EVN N/A
- LAB N/A
- Revenue Next Year
- EVN N/A
- LAB N/A
- P/E Ratio
- EVN $29.94
- LAB N/A
- Revenue Growth
- EVN N/A
- LAB 44.70
- 52 Week Low
- EVN $8.64
- LAB $0.92
- 52 Week High
- EVN $10.45
- LAB $2.32
- Technical
- Relative Strength Index (RSI)
- EVN 53.73
- LAB 37.50
- Support Level
- EVN $10.87
- LAB $1.12
- Resistance Level
- EVN $11.10
- LAB $1.25
- Average True Range (ATR)
- EVN 0.13
- LAB 0.08
- MACD
- EVN -0.01
- LAB -0.02
- Stochastic Oscillator
- EVN 56.41
- LAB 4.41
About EVN Eaton Vance Municipal Income Trust
Eaton Vance Municipal Income Trust is a United States-based diversified, closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax. The trust's portfolio of investments majorly consists of debt instruments of governments, municipal organizations the interest on which is exempt from regular federal income tax and has also some exposure to corporate bonds and other instruments.
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.